Skip to main content
. Author manuscript; available in PMC: 2022 Jun 30.
Published in final edited form as: Compr Physiol. 2021 Jun 30;11(3):2135–2190. doi: 10.1002/cphy.c200023

Figure 9.

Figure 9

Treatment algorithm for pediatric IPAH/HPAH as recommended by the 6th WSPH Pediatric Task Force. ERA, endothelin receptor antagonist; PDE5, phosphodiesterase 5; i.v., intravenous; s.c, subcutaneous. Adapted, with permission, from Rosenzweig EB, et al., 2019 (506). © 2019, The European Respiratory Society.